Epidermylosis Bullosa Completed Phase 4 Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0033122 (Epidermylosis Bullosa)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00231517Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis BullosaTreatment